You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SNF3-subtype

Showing 1 - 25 of 2,351
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial (Fluzoparib, Anastrozole, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 5, 2023

Breast Cancer, Advanced Breast Cancer Trial in Shanghai (Everolimus 10 mg, CDK4/6 Inhibitor SHR6390, Aromatase inhibitor and

Not yet recruiting
  • Breast Cancer
  • Advanced Breast Cancer
  • Everolimus 10 mg
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 14, 2023

Breast Tumor, Breast Cancer, Hormone Receptor Positive Tumor Trial in Shanghai (PIK3CA inhibitor, AKT inhibitor, Carrelizumab)

Recruiting
  • Breast Neoplasm
  • +4 more
  • PIK3CA inhibitor
  • +12 more
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jan 2, 2023

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

National Cohort on Congenital Defects of the Eye

Recruiting
  • Anophthalmia
  • +4 more
    • Paris, Île-de-France, France
      RaDiCo-ACOEIL
    Jul 18, 2023

    Neuronal Ceroid Lipofuscinosis CLN5 Trial in Rochester (NGN-101)

    Recruiting
    • Neuronal Ceroid Lipofuscinosis CLN5
    • NGN-101
    • Rochester, New York
    • +1 more
    Jan 19, 2023

    Neuroendocrine Neoplasia's (NENs), Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) Trial in Basel (161Tb-DOTA-LM3,

    Not yet recruiting
    • Neuroendocrine Neoplasia's (NENs)
    • Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
    • Basel, Switzerland
      Division of Nuclear Medicine, University Hospital Basel
    Apr 27, 2022

    Breast Cancer Metastatic Cancer Trial in Shanghai (Fluzoparib, Dalpiciclib, Fulvestrant/AI)

    Recruiting
    • Breast Cancer Metastatic Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Feb 26, 2023

    Breast Tumor, Breast Cancer, Breast Tumors Trial in Shanghai (Dalpiciclib, Pyrotinib, SHR-A1811)

    Not yet recruiting
    • Breast Neoplasm
    • +9 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center Shanghai, China, 200032
    Oct 13, 2022

    HIV Trial in South Africa (ALVAC-HIV (vCP2438), Bivalent Subtype C gp120/MF59, Placebo)

    Completed
    • HIV Infections
    • ALVAC-HIV (vCP2438)
    • +2 more
    • Mthatha, Eastern Cape, South Africa
    • +13 more
    May 17, 2022

    HIV-1-infection, Subtype b Trial (Decitabine cycle 1, Romidepsin cycle 1, Decitabine cycle 2)

    Recruiting
    • HIV-1-infection, Subtype b
    • Decitabine cycle 1
    • +7 more
    • Bruxelles, Belgium
    • +2 more
    Jan 30, 2023

    HIV Trial in Mozambique, South Africa, Zimbabwe (ALVAC-HIV (vCP2438), Bivalent Subtype C gp120/MF59, Bivalent Subtype C gp120

    Completed
    Has Results
    • HIV Infections
    • ALVAC-HIV (vCP2438)
    • +3 more
    • Maputo, Mozambique
    • +5 more
    Nov 18, 2021

    Parkinson's Disease Trial in Germany, United Kingdom, United States (PTC-589)

    Completed
    Has Results
    • Parkinson's Disease
    • Los Angeles, California
    • +4 more
    Apr 6, 2022

    Calciphylaxis, Calcific Uremic Arteriolopathy Trial in Worldwide (Experimental: SNF472, Placebo Comparator: Placebo,

    Recruiting
    • Calciphylaxis
    • Calcific Uremic Arteriolopathy
    • Experimental: SNF472
    • +2 more
    • Huntsville, Alabama
    • +70 more
    Nov 10, 2021

    ADjuvant chemotherAPy After Curative Intent resecTion of

    Recruiting
    • Ampullary Adenocarcinoma
    • Brescia, BS, Italy
      Fondazione Poliambulanza
    Oct 3, 2023

    Cardiovascular Diseases, Cardiovascular Abnormalities, Calcifications, Vascular Trial in Spain, United Kingdom, United States

    Completed
    Has Results
    • Cardiovascular Diseases
    • +5 more
    • Bakersfield, California
    • +74 more
    Mar 19, 2021

    Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

    Not yet recruiting
    • Breast Cancer
    • Triple Negative Breast Cancer
    • (no location specified)
    Jun 11, 2023

    Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

    Not yet recruiting
    • Triple-Negative Breast Cancer
    • Trastuzumab Deruxtecan
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jul 12, 2023

    Triple-Negative Breast Cancer Trial in Shanghai (VEGFR, nab-paclitaxel, Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin)

    Recruiting
    • Triple-Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Mar 28, 2023

    Diffuse Large B Cell Lymphoma (DLBCL) Trial in Shanghai (Orelabrutinib + R-CHOP, Placebo + R-CHOP)

    Recruiting
    • Diffuse Large B Cell Lymphoma (DLBCL)
    • Orelabrutinib + R-CHOP
    • Placebo + R-CHOP
    • Shanghai, Shanghai, China
      Shanghai Ruijing Hospital
    Nov 28, 2022

    Triple-negative Breast Cancer Trial in Shanghai (Pyrotinib with Capecitabine, AR inhibitor combined with everolimus(B1) or

    Recruiting
    • Triple-negative Breast Cancer
    • Pyrotinib with Capecitabine
    • +6 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 8, 2022

    SURPASS Retrospective Study

    Completed
    • Breast Cancer
    • +3 more
    • Sentinel lymph node biopsy followed by axillary lymph node dissection
    • (no location specified)
    Mar 20, 2023

    Better App:Development and Evaluation ofDigital Lifestyle

    Not yet recruiting
    • Healthy Lifestyle
    • Health Behavior
    • BETTERapp
    • (no location specified)
    Apr 18, 2023

    Activated B-cell DLBCL (ABC DLBCL) Trial in United Kingdom, United States (Acalabrutinib)

    Active, not recruiting
    Has Results
    • Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)
    • Los Angeles, California
    • +6 more
    Dec 1, 2022

    68Ga-Pentixafor PET/CT for Subtyping Diagnosis of Primary

    Completed
    • Primary Aldosteronism
    • 68Ga-Pentixafor PET/CT imaging
    • Chongqing, Chongqing, China
      The First Affilated Hospital of Chongqing Medical University
    Jul 13, 2022